During the assembly of the nucleocapsid of the hepatitis B virus a pro
tein kinase, probably of cellular origin, is encapsidated. This enzyme
phosphorylates serine residue(s) localized within the lumen of the pa
rticle. By using purified, liver-derived core particles, we characteri
zed the protein kinase activity in the presence of different ions and
inhibitors. Controls were performed with cAMP-dependent protein kinase
(PKA) and protein kinase C (PKC) and recombinant core particles. We s
howed that the endogenous protein kinase of the core particles was not
inhibited by H89, a specific inhibitor of PKA. Staurosporine, a selec
tive inhibitor of PKC inhibited the endogenous kinase activity only wi
thin the first minutes of the reaction. In contrast, quercetine, a sel
ective inhibitor of the protein kinase M (PKM) did not inhibit during
the first minutes but inhibited efficiently during later phases of inc
ubation. PKM represents an enzymatically active proteolytic fragment o
f PKC. These results suggest that PKC is encapsidated into human core
particles and is converted to PKM during the in vitro reaction. This c
onclusion implies the association of a protease activity localized wit
h the HBV nucleocapsid inside liver-derived core particles.